Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$884M |
| 2 |
JD.com
JD
|
+$784M |
| 3 |
Dollar General
DG
|
+$667M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
Starbucks
SBUX
|
+$249M |
Top Sells
| 1 |
Union Pacific
UNP
|
+$611M |
| 2 |
Mondelez International
MDLZ
|
+$554M |
| 3 |
Alibaba
BABA
|
+$438M |
| 4 |
CELG
Celgene Corp
CELG
|
+$408M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$362M |
Sector Composition
| 1 | Healthcare | 21.02% |
| 2 | Consumer Discretionary | 16.05% |
| 3 | Technology | 13.06% |
| 4 | Communication Services | 12.46% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Qualys
QLYS
$4.82B
| $10.5M | 0.01% |
259,063
-9,929
| -4% | -$401K |
|
|
PSXP
502
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $10.4M | 0.01% |
144,573
+43,373
| +43% | +$3.12M |
|
503
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $10.2M | 0.01% |
+353,363
| New | +$10.2M |
|
|
RLYP
504
DELISTED
RELYPSA INC COM
RLYP
| $10M | 0.01% |
302,200
+1,998
| +0.7% | +$66.1K |
|
505
Century Aluminum
CENX
$2.02B
| $9.93M | 0.01% |
952,285
+19,700
| +2% | +$205K |
|
506
MPLX
MPLX
$51.2B
| $9.83M | 0.01% |
137,735
+47,676
| +53% | +$3.4M |
|
|
ACOR
507
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $9.01M | 0.01% |
2,252
-1,060
| -32% | -$4.24M |
|
|
DERM
508
DELISTED
Dermira, Inc.
DERM
| $8.95M | 0.01% |
510,106
+2,403
| +0.5% | +$42.2K |
|
509
FerroAtlántica
GSM
$776M
| $8.89M | 0.01% |
+502,418
| New | +$8.89M |
|
|
PRTY
510
DELISTED
Party City Holdco Inc.
PRTY
| $8.64M | 0.01% |
+426,241
| New | +$8.64M |
|
|
ALPN
511
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $8.53M | 0.01% |
+144,296
| New | +$8.53M |
|
|
ETP
512
DELISTED
Energy Transfer Partners L.p.
ETP
| $8.2M | 0.01% |
157,171
+47,870
| +44% | +$2.5M |
|
|
DSCI
513
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $8.17M | 0.01% |
1,140,446
+3,518
| +0.3% | +$25.2K |
|
|
ACGN
514
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $8M | 0.01% |
15,879
+117
| +0.7% | +$59K |
|
|
AGN.PRA
515
DELISTED
Allergan plc.
AGN.PRA
| $7.84M | 0.01% |
+7,500
| New | +$7.84M |
|
|
PRTK
516
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $7.77M | 0.01% |
+301,514
| New | +$7.77M |
|
|
NVRO
517
DELISTED
NEVRO CORP.
NVRO
| $7.35M | 0.01% |
136,760
-8,186
| -6% | -$440K |
|
518
Rocket Pharmaceuticals
RCKT
$344M
| $7.23M | 0.01% |
368,614
+118,384
| +47% | +$2.32M |
|
|
TEP
519
DELISTED
Tallgrass Energy Partners, LP
TEP
| $6.58M | 0.01% |
136,837
+4,355
| +3% | +$209K |
|
|
ADAP
520
Adaptimmune Therapeutics
ADAP
$13.4M
| $6.42M | 0.01% |
+350,000
| New | +$6.42M |
|
|
EPZM
521
DELISTED
Epizyme, Inc
EPZM
| $6.05M | 0.01% |
252,117
+1,979
| +0.8% | +$47.5K |
|
|
BLCM
522
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $5.87M | 0.01% |
27,573
-38,070
| -58% | -$8.1M |
|
523
Esperion Therapeutics
ESPR
$516M
| $5.78M | 0.01% |
70,720
+673
| +1% | +$55K |
|
524
SCYNEXIS
SCYX
$40M
| $5.24M | ﹤0.01% |
+59,651
| New | +$5.24M |
|
|
TRNX
525
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $5.19M | ﹤0.01% |
207,769
+2,091
| +1% | +$52.3K |
|